Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients
17.9.2022 16:02:00 EEST | Business Wire | Press release
Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To-Unload (STEMI DTU) pilot trial data show significantly reduced infarct size in patients who received left ventricular (LV) unloading with Impella CP for 30 minutes prior to their percutaneous coronary intervention (PCI) compared to patients who received LV unloading followed by immediate PCI. The data were presented today during the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference in Boston by Navin K. Kapur, MD, executive director of the Cardiovascular Center for Research and Innovation (CVCRI) at Tufts Medical Center and the principal investigator for the STEMI DTU pivotal randomized controlled trial.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220917005003/en/
The STEMI DTU pilot trial demonstrated for the first time that LV unloading using the Impella CP® heart pump with a 30-minute delay before reperfusion is safe and feasible. (Graphic: Business Wire)
The new analysis compared infarct size in 32 patients from the STEMI DTU pilot trial who met all inclusion and exclusion criteria. All patients experienced an anterior STEMI and completed one of two treatment protocols – LV unloading with Impella CP followed by immediate PCI (n=15) or LV unloading with Impella CP for 30 minutes prior to delayed PCI (n=17). Cardiac magnetic resonance (CMR) imaging performed three-to-five days after PCI was used to determine infarct size (IS) normalized to the area at risk (AAR). Results showed that the infarct size normalized to the area at risk was significantly lower in the delayed PCI group compared to the immediate PCI group (IS/AAR: 47±16 vs. 60±16, p=0.02), which translates to a 22% relative and 13% absolute reduction in IS/AAR.
“Results from this analysis are early, but promising, indicating that in STEMI patients, unloading the left ventricle with Impella CP for 30 minutes and delaying PCI could potentially help improve patient outcomes by reducing damage to the heart muscle and helping prevent heart failure,” said Dr. Kapur.
Myocardial damage can lead to heart failure. Every 5% increase in infarct size is associated with a 20% increase in relative hazard for all-cause mortality or hospitalization for heart failure within one year after a primary PCI (JACC, 2016). Coronary artery disease is the number one cause of death in the United States and 47% of women and 36% of men over the age of 45 will die within five years of their first heart attack (Circulation, 2019).
The STEMI DTU pilot study demonstrated for the first time that LV unloading using Impella CP with a 30-minute delay before reperfusion via PCI is feasible, safe and not associated with an increase in infarct size. The pilot study led to the STEMI DTU pivotal randomized controlled trial, which began in 2019 and is actively enrolling patients. The pivotal trial is testing the hypothesis that compared to PCI alone, LV unloading for 30 minutes prior to PCI can reduce myocardial damage and future heart failure-related events due to a heart attack.
ABOUT IMPELLA HEART PUMPS
The Impella 2.5® and Impella CP® with SmartAssist® are U.S. FDA approved to treat certain advanced heart failure patients undergoing elective and urgent percutaneous coronary interventions (PCI), such as stenting or balloon angioplasty, to reopen blocked coronary arteries.
Impella 2.5, Impella CP®, Impella CP with SmartAssist, Impella 5.0®, Impella LD®, and Impella 5.5® with SmartAssist® are U.S. FDA approved to treat heart attack or cardiomyopathy patients in cardiogenic shock and have the unique ability to enable native heart recovery, allowing patients to return home with their own heart.
Impella heart pumps are not FDA approved for use in STEMI patients without cardiogenic shock.
ABOUT ABIOMED
Based in Danvers, Massachusetts, USA, Abiomed (Nasdaq: ABMD) is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest and recover by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit abiomed.com.
FORWARD-LOOKING STATEMENTS
Any forward-looking statements are subject to risks and uncertainties such as those described in Abiomed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220917005003/en/
Contact information
Media Contact:
Jenny Leary
Associate Director, U.S. Communications
+1 (978) 882-8491
jleary@abiomed.com
Investor Contact:
Todd Trapp
Executive Vice President and Chief Financial Officer
+1 (978) 646-1680
ttrapp@abiomed.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Confirmed as the World’s Leading Food Company for Reputation - Ranking 9 th Overall Globally8.4.2026 15:42:00 EEST | Press release
For the third year in a row, Barilla is confirmed as the world’s leading company in the food sector for reputation in the Global RepTrak® 100 ranking conducted by RepTrak, which since 1999 has annually analyzed the companies with the strongest reputations worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407912080/en/ In the 2026 ranking, the Group reaches 9th place overall, moving up 16 spots compared to 2025 (ranked at 25th) and entering the global Top 10, confirming the company’s steady reputation‑building journey developed over the years. This result reflects Barilla’s ability to combine product quality, industrial vision and social responsibility – factors that are increasingly central to the assessment of corporate reputation. The study evaluates key elements including performance, innovation, governance, sustainability and the ability to generate long‑term trust. “In today’s turbulent macroeconomic environm
Adtran launches Ensemble Cloudlet multi‑node to simplify high‑availability edge AI deployments8.4.2026 15:30:00 EEST | Press release
Adtran today launched its Ensemble Cloudlet multi‑node solution, a high‑availability edge platform that supports AI inference and agentic AI deployments where low latency, resilience and secure local processing are critical. Removing the complexity and cost barriers that slow modern service and enterprise deployments, the solution creates a single, logical cloud with distributed storage and automated failover, starting with just two nodes. Built on Cloudlet OS and managed through Ensemble EdgeView orchestration, it enables zero-touch deployment and unified lifecycle management, providing a simple, scalable foundation for running networking, IT and emerging AI workloads at the edge. “Deploying high‑availability edge infrastructure for AI has often demanded a lot of cloud wizardry – stitching together storage, networking and failover manually. With Ensemble Cloudlet multi‑node, we’ve made the hard parts easy,” said Christoph Glingener, CTO of Adtran. “The nodes build their own shared sto
ZincFive Announces Nickel-Zinc Retrofit Kit to Modernize Existing UPS Energy Storage Infrastructure8.4.2026 15:05:00 EEST | Press release
ZincFive®, the global leader in nickel-zinc (NiZn) battery-based solutions for immediate power applications, today announced the NiZn Retrofit Kit, an uninterruptible power supply (UPS) energy storage solution designed to bring the benefits of modern battery chemistry to existing UPS battery systems in mission-critical environments. The NiZn Retrofit Kit will enable data center operators and service providers to replace legacy valve-regulated lead-acid (VRLA) batteries with ZincFive’s long-life, high-performance nickel-zinc technology without requiring cabinet enclosure replacement, system redesign, or operational disruption. As data center power demands continue to increase, operators face growing pressure to improve reliability, reduce lifecycle costs, and meet sustainability targets. At the same time, much of the global UPS energy storage system installed base remains constrained by legacy VRLA batteries, where full storage system replacement introduces significant cost, complexity,
Sagard and Unigestion Announce Closing of Partnership Transaction8.4.2026 15:00:00 EEST | Press release
Sagard, a global multi-strategy alternative asset management firm with over $45 billion USD1 in assets under management and Unigestion Private Equity Holding SA (UNG PE), a leading middle market private equity provider, today announced the successful closing of their combination transaction, originally announced in September. Completion of this transaction marks the formal launch of the partnership and the integration of UNG PE into Sagard’s global middle-market private equity platform, Sagard Private Equity Solutions (SPES). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408374851/en/ “We are thrilled to formally begin our partnership with the Unigestion team,” said Paul Desmarais III, Chairman & CEO of Sagard. “This milestone solidifies our joint commitment to building a global private equity platform positioned for long-term growth alongside our clients and teams.” “The closing of this transaction represents an excitin
New Research Finds AI Is Now Foundational to Modern Marketing8.4.2026 15:00:00 EEST | Press release
NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced its participation in a new marketing research study conducted by Callan Consulting, a Silicon Valley executive marketing consulting firm, joining 18 B2B and B2C technology companies to examine how AI is reshaping modern marketing organizations, marking a clear shift from early experimentation to embedded, enterprise‑wide adoption. According to the State of AI in Technology Marketing 2026 report, based on in‑depth interviews with CMOs and senior marketing leaders at the participating companies, the study finds that AI is becoming rapidly integrated across core marketing teams and workflows—from content development and research to campaign optimization and analytics. As adoption deepens, data quality, accessibility, and governance are emerging as critical priorities. "AI doesn't change what great marketing is supposed to do. It just removes the excuses for not doing it," said Gabie Boko, Chief Marketing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom